|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$64.54 |
$65.80 |
$61.64 |
$63.42 |
3.06M | 04/22/2024 |
$64.13 |
$64.94 |
$62.30 |
$63.85 |
1.56M | 04/23/2024 |
$64.45 |
$67.58 |
$63.51 |
$64.93 |
2.03M | 04/24/2024 |
$65.75 |
$67.78 |
$64.43 |
$65.07 |
2.58M | 04/25/2024 |
$63.00 |
$69.17 |
$62.56 |
$68.86 |
3.52M |
|
Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapies for metabolic and endocrine disorders. Co.'s primary clinical program's drug candidate, VK2809, is an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß). Co. is also developing VK0214, which is also an orally available, tissue and receptor-subtype selective agonist of TRß for X-linked adrenoleukodystrophy, a rare X-linked, inherited neurological disorder characterized by a breakdown in the protective barriers surrounding brain and nerve cells. | |
|
Viking Therapeutics (VKTX) has the following price history information. Looking back at VKTX historical stock prices for the last five trading days, on April 19, 2024, VKTX opened at $64.54, traded as high as $65.80 and as low as $61.64, and closed at $63.42. Trading volume was a total of 3.06M shares. On April 22, 2024, VKTX opened at $64.13, traded as high as $64.94 and as low as $62.30, and closed at $63.85. Trading volume was a total of 1.56M shares. On April 23, 2024, VKTX opened at $64.45, traded as high as $67.58 and as low as $63.51, and closed at $64.93. Trading volume was a total of 2.03M shares. On April 24, 2024, VKTX opened at $65.75, traded as high as $67.78 and as low as $64.43, and closed at $65.07. Trading volume was a total of 2.58M shares. On April 25, 2024, VKTX opened at $63.00, traded as high as $69.17 and as low as $62.56, and closed at $68.86. Trading volume was a total of 3.52M shares.
VKTX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Viking Therapeutics shares, starting with a $10,000 purchase of VKTX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2015 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$8.96 |
|
End price/share: |
$68.86 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
668.53% |
|
Average Annual Total Return: |
25.44% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$76,851.92 |
|
Years: |
9.00 |
|
|
|
Date |
Close |
04/19/2024 | $63.42 | 04/22/2024 | $63.85 | 04/23/2024 | $64.93 | 04/24/2024 | $65.07 | 04/25/2024 | $68.86 |
|
|